Beijing Konruns Pharmaceutical Co Ltd
SSE:603590
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Beijing Konruns Pharmaceutical Co Ltd
SSE:603590
|
CN |
|
Cidara Therapeutics Inc
NASDAQ:CDTX
|
US |
|
C
|
Centurion Corporation Ltd
SGX:OU8
|
SG |
|
D
|
Datatec Ltd
JSE:DTC
|
ZA |
|
CrowdWorks Inc
TSE:3900
|
JP |
|
URU Metals Ltd
LSE:URU
|
CA |
Dividends
Dividend Yield
Beijing Konruns Pharmaceutical Co Ltd
| Current Yield | |
| Min Yield | |
| Max Yield | |
| Average Yield | |
| Median Yield |
Dividend Per Share
Beijing Konruns Pharmaceutical Co Ltd
Beijing Konruns Pharmaceutical Co Ltd have
decreased
by 0%.
Payout Ratio
Beijing Konruns Pharmaceutical Co Ltd
Peers Comparison
Dividends
Shareholder Yield
Current shareholder yield for
Beijing Konruns Pharmaceutical Co Ltd is
hidden
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Buybacks
Buyback Yield measures how much a company reduces its outstanding shares through repurchases, expressed as a percentage.
This metric directly reflects the company’s efforts to return value to shareholders. By reducing the number of shares, buybacks can increase earnings per share and potentially boost the stock's price.
Peers Comparison
Buybacks
Debt Paydown
Debt Paydown Yield measures the amount of debt a company repays within a specific period, shown as a percentage of its market capitalization.
This metric indicates how the company is using its capital to decrease financial liabilities, which can strengthen its financial health and potentially enhance shareholder value.
Peers Comparison
Debt Paydown
Price Appreciation
Price
Beijing Konruns Pharmaceutical Co Ltd
| Average Annual Return | -4.17% |
| Standard Deviation of Annual Returns | 38.85% |
| Max Drawdown | -51% |
| Market Capitalization | 5.7B CNY |
| Shares Outstanding | 159 010 000 |
| Percentage of Shares Shorted |
N/A
|